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FACTS FOr COMMuNiTy MEMBErS	
Tolerance	develops	when	someone	uses	
an	opioid	drug	regularly,	so	that	their	
body	becomes	accustomed	to	the	drug	
and	needs	a	larger	or	more	frequent	dose	
to	continue	to	experience	the	same	effect.
Loss of tolerance	occurs	when	someone	
stops	taking	an	opioid	after	long-term	use.	
When	someone	loses	tolerance		
and	then	takes	the	opioid	drug	again,		
they	can	experience	serious	adverse	
effects,	including	overdose,	even	if		
they	take	an	amount	that	caused		
them	no	problem	in	the	past.

SCOPE OF THE PrOBLEM 
Opiate	overdose	continues	to	be	a	major	public	health	prob-lem	in	the	United	States.	It	has	contributed	significantly	to		accidental	deaths	among	those	who	use,	misuse	or	abuse	illic-
it	and	prescription	opioid	analgesics.	In	fact,	overdose	deaths	involv-
ing	prescription	opioid	analgesics	have	increased	to	almost	17,000	
deaths	a	year	[1,2].	As	a	result,	drug	poisoning	deaths	in	the	U.S.	
almost	doubled	between	2001	and	2010	[1].	This	increase	coincided	
with	a	nearly	fourfold	increase	in	the	use	of	prescribed	opioids	for	the	
treatment	of	pain	[3].	
WHAT ArE OPiOiDS? Opioids	include	illegal	drugs	such	as	heroin	
and	prescription	medications	used	to	treat	pain	such	as	morphine,	
codeine,	methadone,	oxycodone	(Oxycontin,	Percodan,	Percocet),	
hydrocodone	(Vicodin,	Lortab,	Norco),	fentanyl	(Duragesic,	Fentora),	
hydromorphone	(Dilaudid,	Exalgo),	and	buprenorphine	(Subutex,	
Suboxone).
Opioids	work	by	binding	to	specific	receptors	in	the	brain,	spinal	
cord	and	gastrointestinal	tract.	In	doing	so,	they	minimize	the	body’s	
perception	of	pain.	Stimulating	the	opioid	receptors	or	“reward	
	centers”	in	the	brain	also	can	trigger	other	systems	of	the	body,		
such	as	those	responsible	for	regulating	mood,	breathing	and		
blood	pressure.		
HOW DOES OVErDOSE OCCur? A	variety	of	effects	can	occur	after	
a	person	takes	opioids,	ranging	from	pleasure	to	nausea,	vomiting,	
severe	allergic	reactions	(anaphylaxis)	and	overdose,	in	which	breath-
ing	and	heartbeat	slow	or	even	stop.
Opioid	overdose	can	occur	when	a	patient	deliberately	misuses	
a	prescription	opioid	or	an	illicit	drug	such	as	heroin.	It	also	can	
occur	when	a	patient	takes	an	opioid	as	directed,	but	the	prescriber	
miscalculated	the	opioid	dose	or	an	error	was	made	by	the	
dispensing	pharmacist	or	the	patient	misunderstood	the	directions	
for	use.	
Also	at	risk	is	the	person	who	takes	opioid	medications	
prescribed	for	someone	else,	as	is	the	individual	who	combines	
opioids	—	prescribed	or	illicit	—	with	alcohol,	certain	other	
medications,	and	even	some	over-the-counter	products	that	
depress	breathing,	heart	rate,	and	other	functions	of	the	central	
nervous	system	[4].
WHO iS AT riSK? Anyone	who	uses	opioids	
for	long-term	management	of	chronic	cancer	
or	non-cancer	pain	is	at	risk	for	opioid	
overdose,	as	are	persons	who	use	heroin	[5].	
Others	at	risk	include	persons	who	are:
n	 Receiving	rotating	opioid	medication	
	regimens	(thus	at	risk	for	incomplete	
cross-tolerance).
n	 Discharged	from	emergency	medical	care	
following	opioid	intoxication	or	poisoning.
n	 At	high	risk	for	overdose	because	of	a	
legitimate	medical	need	for	analgesia,	
coupled	with	a	suspected	or	confirmed	
history	of	substance	abuse,	dependence,	
or	non-medical	use	of	prescription	or		
illicit	opioids.
n	 Completing	mandatory	opioid	detoxifica-
tion	or	abstinent	for	a	period	of	time	(and	
presumably	with	reduced	opioid	tolerance	
and	high	risk	of	relapse	to	opioid	use).
n	 Recently	released	from	incarceration	and	
a	past	user	or	abuser	of	opioids	(and	
presumably	with	reduced	opioid	tolerance	
and	high	risk	of	relapse	to	opioid	use).
STrATEGiES TO PrEVENT OVErDOSE DEATHS
STrATEGy 1: Encourage providers, persons at high risk, family members and others to 
learn how to prevent and manage opioid overdose. Providers	should	be	encouraged	to	keep	
their	knowledge	current	about	evidence-based	practices	for	the	use	of	opioid	analgesics	to	
manage	pain,	as	well	as	specific	steps	to	prevent	and	manage	opioid	overdose.
Federally	funded	Continuing	Medical	Education	courses	are	available	to	providers	at	
no	charge	at	www.OpioidPrescribing.com	(five	courses	funded	by	the	Substance	Abuse	
and	Mental	Health	Services	Administration)	and	on	MedScape	(two	courses	funded	by	the	
National	Institute	on	Drug	Abuse).
Helpful	information	for	laypersons	on	how	to	prevent	and	manage	overdose	is	available	
from	Project	Lazarus	at	http://projectlazarus.org/	or	from	the	Massachusetts	Health	
Promotion	Clearinghouse	at	www.maclearinghouse.org.
STrATEGy 2: Ensure access to treatment for individuals who are misusing or addicted to 
opioids or who have other substance use disorders.	Effective	treatment	of	substance	use	
disorders	can	reduce	the	risk	of	overdose	and	help	overdose	survivors	attain	a	healthier	life.	
Medication-assisted	treatment,	as	well	as	counseling	and	other	supportive	services,	can		
be	obtained	at	SAMHSA-certified	and	DEA-registered	opioid	treatment	programs	(OTPs),	
as	well	as	from	physicians	who	are	trained	to	provide	care	in	office-based	settings	with	
medications	such	as	buprenorphine	and	naltrexone.	
Information	on	treatment	services	available	in	or	near	your	community	can	be	obtained	
from	state	health	departments,	state	alcohol	and	drug	agencies,	or	from	the	federal	
Substance	Abuse	and	Mental	Health	Services	Administration	(see	page	6).
STrATEGy 3: Ensure ready access to naloxone. Opioid	overdose-related	deaths	can	be	
prevented	when	naloxone	is	administered	in	a	timely	manner.	As	a	narcotic	antagonist,	
naloxone	displaces	opiates	from	receptor	sites	in	the	brain	and	reverses	respiratory	
depression	that	usually	is	the	cause	of	overdose	deaths	[5].	During the period of time  
when an overdose can become fatal, respiratory depression can be reversed by giving the 
individual naloxone	[4].
On	the	other	hand,	naloxone	is	not effective	in	treating	overdoses	of	benzodiazepines	
(such	as	Valium,	Xanax,	or	Klonopin),	barbiturates	(Seconal	or	Fiorinal),	clonidine,	Elavil,	
GHB,	or	ketamine.	It	also	is	not	effective	in	overdoses	with	stimulants,	such	as	cocaine		
and	amphetamines	(including	methamphetamine	and	Ecstasy).	However	if	opioids	are		
taken	in	combination	with	other	sedatives	or	stimulants,	naloxone	may	be	helpful.
Naloxone	injection	has	been	approved	by	FDA	and	used	for	more	than	40	years	by	
emergency	medical	services	(EMS)	personnel	to	reverse	opioid	overdose	and	resuscitate	
persons	who	otherwise	might	have	died	in	the	absence	of	treatment	[6].	
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Naloxone	has	no	psychoactive	effects	and	does	not	present	any	potential	for	abuse		
[1,4].	Injectable	naloxone	is	relatively	inexpensive.	It	typically	is	supplied	as	a	kit	with	two	
syringes,	at	a	cost	of	about	$6	per	dose	and	$15	per	kit	[7].
For	these	reasons,	it	is	important	to	determine	whether	local	EMS	personnel	or	other		
first	responders	have	been	trained	to	care	for	overdose,	and	whether	they	are	allowed	to		
stock	naloxone	in	their	drug	kits.	In	some	jurisdictions,	the	law	protects	responders	from		
civil	liability	and	criminal	prosecution	for	administering	naloxone.	So-called	“Good	Samaritan”	
laws	are	in	effect	in	10	states	and	the	District	of	Columbia,	and	are	being	considered	
by	legislatures	in	at	least	a	half-dozen	other	states	[8].	Such	laws	provide	protection	
against	prosecution	for	both	the	overdose	victim	and	those	who	respond	to	overdose.	To	
find	states	that	have	adopted	relevant	laws,	visit	the	CDC’s	website	at:	www.cdc.gov/
HomeandRecreational	Safety/Poisoning/laws/immunity.html.
STrATEGy 4: Encourage the public to call 911. An	individual	who	is	experiencing	opioid	
overdose	needs	immediate	medical	attention.	An	essential	first	step	is	to	get	help	from	
someone	with	medical	expertise	as	quickly	as	possible	[9,	10].	Therefore,	members	of	the	
public	should	be	encouraged	to	call	911.	All	they	have	to	say	is,	“Someone	is	not	breathing”	
and	give	a	clear	address	and	location.
STrATEGy 5: Encourage prescribers to use state Prescription Drug Monitoring Programs 
(PDMPs). State	Prescription	Drug	Monitoring	Programs	(PDMPs)	have	emerged	as	a	key	
strategy	for	addressing	the	misuse	and	abuse	of	prescription	opioids	and	thus	preventing	
opioid	overdoses	and	deaths.	Specifically,	prescribers	can	check	their	state’s	PDMP		
database	to	determine	whether	a	patient	is	filling	the	prescriptions	provided	and/or		
obtaining	prescriptions	for	the	same	or	similar	drug	from	multiple	physicians.
While	a	majority	of	states	now	have	operational	PDMPs,	the	programs	differ	from	state		
to	state	in	terms	of	the	exact	information	collected,	how	soon	that	information	is	available		
to	physicians,	and	who	may	access	the	data.	Therefore,	information	about	the	program	in		
a	particular	state	is	best	obtained	directly	from	the	state	PDMP	or	from	the	board	of		
medicine	or	pharmacy.
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rESOurCES FOr COMMuNiTiES
Resources	that	may	be	useful	to	local	communities	and	organizations		
are	found	at	the	following	websites:
Substance Abuse and Mental Health Services Administration (SAMHSA)
n	 National	Treatment	Referral	Helpline	
1-800-662-HELP	(4357)	or	1-800-487-4889		
(TDD	—	for	hearing	impaired)
n	 National	Substance	Abuse	Treatment	Facility	Locator:		
www.findtreatment.samhsa.gov/TreatmentLocator	to	search		
by	state,	city,	county,	and	zip	code
n	 Buprenorphine	Physician	&	Treatment	Program	Locator:		
www.buprenorphine.samhsa.gov/bwns_locator
n	 State	Substance	Abuse	Agencies:		
www.findtreatment.samhsa.gov/ufds/abusedirectors
n	 Center	for	Behavioral	Health	Statistics	and	Quality	(CBHSQ):		
www.samhsa.gov/data/
n	 SAMHSA	Publications:	www.store.samhsa.gov	
1-877-SAMHSA	(1-877-726-4727)
Centers for Disease Control and Prevention (CDC) 
www.cdc.gov/Features/VitalSigns/PainkillerOverdoses	
www.cdc.gov/Homeand	RecreationSafety/Poisoning
White House Office of National Drug Control Policy (ONDCP)
State	and	Local	Information:	www.whitehouse.gov/ondcp/state-map
Association of State and Territorial Health Officials (ASTHO) 
Prescription	Drug	Overdose:	State	Health	Agencies	Respond	(2008):		
www.astho.org
National Association of State Alcohol and Drug Abuse Directors (NASADAD) 
State	Issue	Brief	on	Methadone	Overdose	Deaths:		
www.nasadad.org/nasadad-reports
National Association of State EMS Officials (NASEMSO) 
National	Emergency	Medical	Services	Education	Standards:		
www.nasemso.org
American Association for the Treatment of Opioid Dependence (AATOD) 
Prevalence	of	Prescription	Opioid	Abuse:	www.aatod.org/prevalence.html
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